论文部分内容阅读
目的分析依那西普对类风湿关节炎患者血清超敏C反应蛋白的影响.方法选取2012年6月到2014年12月到我院进行类风湿关节炎治疗患者80例作为具体的研究对象.随机进行分组.其中对照组为40例.研究组为40例.给予对照组甲氨蝶呤.治疗方法 .给予研究组依那西普治疗方法 .对两组患者治疗疗效.治疗前后血沉(ESR)、血清超敏C反应蛋白(hs-CRP)、前后类风湿因子(RF)进行分析和对比.结果给予两种不同的治疗方法后.研究组的治疗总有效率要明显的高于对照组.研究组在血沉(ESR).血清超敏C反应蛋白(hs-CRP)、前后类风湿因子(RF)的水平要明显的低于对照组.组间数据对比差异明显.(P<0.05)具有统计学意义.讨论:对类风湿关节炎患者来说.使用依那西普来进行治疗.可以有效的降低血清超敏C反应蛋白(hs-CRP)的水平。
Objective To analyze the effect of etanercept on serum high-sensitivity C-reactive protein in patients with rheumatoid arthritis.Methods Eighty patients with rheumatoid arthritis who were admitted to our hospital from June 2012 to December 2014 were selected as the specific subjects. Were randomly divided into groups.Among them, the control group was 40 cases.The study group was 40 cases.The control group methotrexate.Methods: The study group was treated with etanercept.The curative effect of the two groups of patients.The ESR ), Serum hs-CRP and rheumatoid factor (RF) before and after treatment were analyzed and compared.Results After the treatment of two different methods, the total effective rate of the study group was significantly higher than that of the control group The levels of ESR, hs-CRP, and the level of rheumatoid factor (RF) in the study group were significantly lower than those in the control group, and there was significant difference between the two groups (P <0.05) With statistical significance.Discussion: For rheumatoid arthritis patients, the treatment with etanercept can effectively reduce the level of serum hs-CRP.